Autism Spectrum Disorder Therapeutics Market Size to Surpass USD 3.42 Billion by 2030, exhibiting a CAGR of 7.9%
31 août 2023 07h24 HE
|
Fortune Business Insights
Pune, India, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The global autism spectrum disorder therapeutics market size was valued at USD 1.93 billion in 2022 and it is projected to grow from USD 2.01 billion...
DisruptABA™ Virtual Conference: Pursuing Radical Honesty and Change in Applied Behavior Analysis
02 août 2023 09h00 HE
|
Verbal Beginnings
COLUMBIA, Md., Aug. 02, 2023 (GLOBE NEWSWIRE) -- The Applied Behavior Analysis (ABA) professional community is eagerly anticipating the groundbreaking virtual conference, DisruptABA™, which is set...
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
31 juil. 2023 08h30 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, July 31, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
PharmAla Received Guidance on ALA-002 from MHRA; Launches Clinical Program with University of Sydney
20 juil. 2023 09h07 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, July 20, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
PaxMedica Grants Exclusive Pharmacy Distribution Rights for PAX-101 to Vox Nova, LLC
06 juil. 2023 08h00 HE
|
PaxMedica, Inc.
· Agreement for PAX-101 (suramin IV) Distribution in the U.S. for up to 7 years · VoxNova will be responsible for physician registration, safety monitoring and reimbursement for treatment, as...
Autism Spectrum Disorder Treatment Market Size to Surpass USD 3.42 billion by 2030, exhibiting a CAGR of 7.9%
21 juin 2023 04h50 HE
|
Fortune Business Insights
Pune, India, June 21, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, global Autism Spectrum Disorder Treatment Market size was valued at USD 1.93 billion in 2022 and is projected...
CAI Neurodiverse Solutions and Drexel University Create Job Opportunities for Philadelphia-area Neurodivergent Graduates
17 mai 2023 09h00 HE
|
CAI
ALLENTOWN, Pa., May 17, 2023 (GLOBE NEWSWIRE) -- CAI, a global technology services firm, and Drexel University’s Center for Autism and Neurodiversity (CAN), a student-centered program that provides...
Little Leaves Behavioral Services Appoints Dr. Ivy Chong Chief Clinical Officer
16 mai 2023 08h40 HE
|
Little Leaves
SILVER SPRING, Md., May 16, 2023 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based behavioral health services and early intervention for preschool-aged...
Axial Therapeutics Announces Age Expansion in Global Phase 2b Clinical Trial for Irritability Associated with Autism Spectrum Disorder (ASD)
04 avr. 2023 08h00 HE
|
Axial Therapeutics
-- Children aged 5 to 17 with autism are now eligible to enroll in the clinical trial of AB-2004, a gut targeted, molecular therapeutic -- -- Novel small molecule microbiome approach focused on...
Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics
29 mars 2023 08h00 HE
|
Axial Therapeutics
– Phase 2b clinical trial for AB-2004 in autism irritability ongoing and enrollment anticipated to be complete by end of 2023 – – IND-enabling studies ongoing for Parkinson’s Disease development...